OHSU Maps Brain Protein That Could Stop Stroke Damage

For the first time ever, scientists have mapped a tiny protein in the human brain that could become a game changer for stroke patients.

Researchers at Oregon Health & Science University used advanced imaging technology to capture six detailed views of a membrane protein called ASIC1a. This protein sits in brain cells and responds to acid levels, playing a role in learning, memory, and how we process fear.

The discovery matters because this protein becomes dangerous during a stroke. When brain tissue loses oxygen, acid levels change and activate ASIC1a, causing additional damage to cells that might otherwise survive.

Lead researcher Dr. Isabelle Baconguis and her team used cryo-electron microscopy to see the protein in stunning 3D detail. They grew human versions of the protein in the lab and exposed them to different acid levels, capturing six distinct shapes the protein takes.

"Previous studies show that when you block this channel, it can be neuroprotective," Baconguis explained. The images her team created now give drug developers an exact blueprint to design medications that shut down ASIC1a during a stroke.

Scientists in Australia are already testing a molecule from spider venom that targets this exact protein. Early results show it improves outcomes in both heart attacks and strokes.

The Bright Side

Timing is everything with stroke treatment. Current interventions must happen within hours of symptoms starting, and many patients suffer permanent disability because damaged brain tissue dies quickly.

A drug that blocks ASIC1a could protect vulnerable brain cells from the moment it enters the bloodstream. More surviving tissue means less severe disabilities for stroke survivors, potentially preserving movement, speech, and memory that would otherwise be lost.

The research, published in Nature Structural & Molecular Biology, represents years of painstaking work. The team's images reveal conformations of ASIC1a that no one had seen before, showing exactly where a drug molecule needs to attach to stop the protein from causing harm.

"The sooner you can protect brain tissue from damage, the less severe disability stroke survivors will have," Baconguis said. With stroke affecting nearly 800,000 Americans each year, a protective treatment could transform outcomes for hundreds of thousands of people.

The breakthrough shows how basic science creates real hope for patients facing devastating conditions.